Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 112

1.

Kinin B1 receptor antagonism is equally efficient as angiotensin receptor 1 antagonism in reducing renal fibrosis in experimental obstructive nephropathy, but is not additive.

Huart A, Klein J, Gonzalez J, Buffin-Meyer B, Neau E, Delage C, Calise D, Ribes D, Schanstra JP, Bascands JL.

Front Pharmacol. 2015 Feb 2;6:8. doi: 10.3389/fphar.2015.00008. eCollection 2015.

2.

miRNAs in urine: a mirror image of kidney disease?

Papadopoulos T, Belliere J, Bascands JL, Neau E, Klein J, Schanstra JP.

Expert Rev Mol Diagn. 2015 Mar;15(3):361-74. doi: 10.1586/14737159.2015.1009449. Epub 2015 Feb 8.

PMID:
25660955
3.

Diagnosis and Prediction of CKD Progression by Assessment of Urinary Peptides.

Schanstra JP, Zürbig P, Alkhalaf A, Argiles A, Bakker SJ, Beige J, Bilo HJ, Chatzikyrkou C, Dakna M, Dawson J, Delles C, Haller H, Haubitz M, Husi H, Jankowski J, Jerums G, Kleefstra N, Kuznetsova T, Maahs DM, Menne J, Mullen W, Ortiz A, Persson F, Rossing P, Ruggenenti P, Rychlik I, Serra AL, Siwy J, Snell-Bergeon J, Spasovski G, Staessen JA, Vlahou A, Mischak H, Vanholder R.

J Am Soc Nephrol. 2015 Jan 14. pii: ASN.2014050423. [Epub ahead of print]

PMID:
25589610
4.

Protein interactome of muscle invasive bladder cancer.

Bhat A, Heinzel A, Mayer B, Perco P, Mühlberger I, Husi H, Merseburger AS, Zoidakis J, Vlahou A, Schanstra JP, Mischak H, Jankowski V.

PLoS One. 2015 Jan 8;10(1):e0116404. doi: 10.1371/journal.pone.0116404. eCollection 2015.

5.

Pretransplant urinary proteome analysis does not predict development of chronic kidney disease after liver transplantation.

Milongo D, Bascands JL, Huart A, Esposito L, Breuil B, Moulos P, Siwy J, Ramírez-Torres A, Ribes D, Lavayssière L, Del Bello A, Muscari F, Alric L, Bureau C, Rostaing L, Schanstra JP, Kamar N.

Liver Int. 2014 Dec 17. doi: 10.1111/liv.12763. [Epub ahead of print]

PMID:
25515948
6.

Specific Macrophage Subtypes Influence the Progression of Rhabdomyolysis-Induced Kidney Injury.

Belliere J, Casemayou A, Ducasse L, Zakaroff-Girard A, Martins F, Iacovoni JS, Guilbeau-Frugier C, Buffin-Meyer B, Pipy B, Chauveau D, Schanstra JP, Bascands JL.

J Am Soc Nephrol. 2014 Sep 30. pii: ASN.2014040320. [Epub ahead of print]

PMID:
25270069
7.

Proteome analysis in the assessment of ageing.

Nkuipou-Kenfack E, Koeck T, Mischak H, Pich A, Schanstra JP, Zürbig P, Schumacher B.

Ageing Res Rev. 2014 Nov;18:74-85. doi: 10.1016/j.arr.2014.09.002. Epub 2014 Sep 22.

PMID:
25257180
8.

Label-free quantitative urinary proteomics identifies the arginase pathway as a new player in congenital obstructive nephropathy.

Lacroix C, Caubet C, Gonzalez-de-Peredo A, Breuil B, Bouyssié D, Stella A, Garrigues L, Le Gall C, Raevel A, Massoubre A, Klein J, Decramer S, Sabourdy F, Bandin F, Burlet-Schiltz O, Monsarrat B, Schanstra JP, Bascands JL.

Mol Cell Proteomics. 2014 Dec;13(12):3421-34. doi: 10.1074/mcp.M114.040121. Epub 2014 Sep 9.

PMID:
25205225
9.

The HNF1B score is a simple tool to select patients for HNF1B gene analysis.

Faguer S, Chassaing N, Bandin F, Prouheze C, Garnier A, Casemayou A, Huart A, Schanstra JP, Calvas P, Decramer S, Chauveau D.

Kidney Int. 2014 Nov;86(5):1007-15. doi: 10.1038/ki.2014.202. Epub 2014 Jun 4.

PMID:
24897035
10.

Proteomics of vitreous humor of patients with exudative age-related macular degeneration.

Koss MJ, Hoffmann J, Nguyen N, Pfister M, Mischak H, Mullen W, Husi H, Rejdak R, Koch F, Jankowski J, Krueger K, Bertelmann T, Klein J, Schanstra JP, Siwy J.

PLoS One. 2014 May 14;9(5):e96895. doi: 10.1371/journal.pone.0096895. eCollection 2014.

11.

Proteomic urinary biomarker approach in renal disease: from discovery to implementation.

Schanstra JP, Mischak H.

Pediatr Nephrol. 2015 May;30(5):713-25. doi: 10.1007/s00467-014-2790-y. Epub 2014 Mar 15.

PMID:
24633400
12.

Multicentre prospective validation of a urinary peptidome-based classifier for the diagnosis of type 2 diabetic nephropathy.

Siwy J, Schanstra JP, Argiles A, Bakker SJ, Beige J, Boucek P, Brand K, Delles C, Duranton F, Fernandez-Fernandez B, Jankowski ML, Al Khatib M, Kunt T, Lajer M, Lichtinghagen R, Lindhardt M, Maahs DM, Mischak H, Mullen W, Navis G, Noutsou M, Ortiz A, Persson F, Petrie JR, Roob JM, Rossing P, Ruggenenti P, Rychlik I, Serra AL, Snell-Bergeon J, Spasovski G, Stojceva-Taneva O, Trillini M, von der Leyen H, Winklhofer-Roob BM, Zürbig P, Jankowski J.

Nephrol Dial Transplant. 2014 Aug;29(8):1563-70. doi: 10.1093/ndt/gfu039. Epub 2014 Mar 2.

PMID:
24589724
13.

Proteome-based systems biology analysis of the diabetic mouse aorta reveals major changes in fatty acid biosynthesis as potential hallmark in diabetes mellitus-associated vascular disease.

Husi H, Van Agtmael T, Mullen W, Bahlmann FH, Schanstra JP, Vlahou A, Delles C, Perco P, Mischak H.

Circ Cardiovasc Genet. 2014 Apr;7(2):161-70. doi: 10.1161/CIRCGENETICS.113.000196. Epub 2014 Feb 26.

14.

Classical MALDI-MS versus CE-based ESI-MS proteomic profiling in urine for clinical applications.

Albalat A, Husi H, Stalmach A, Schanstra JP, Mischak H.

Bioanalysis. 2014 Jan;6(2):247-66. doi: 10.4155/bio.13.313. Review.

PMID:
24423599
15.

Clinical proteomics in obstetrics and neonatology.

Klein J, Buffin-Meyer B, Mullen W, Carty DM, Delles C, Vlahou A, Mischak H, Decramer S, Bascands JL, Schanstra JP.

Expert Rev Proteomics. 2014 Feb;11(1):75-89. doi: 10.1586/14789450.2014.872564. Epub 2014 Jan 3. Review.

PMID:
24404900
16.

Discovery and validation of urinary biomarkers for detection of renal cell carcinoma.

Frantzi M, Metzger J, Banks RE, Husi H, Klein J, Dakna M, Mullen W, Cartledge JJ, Schanstra JP, Brand K, Kuczyk MA, Mischak H, Vlahou A, Theodorescu D, Merseburger AS.

J Proteomics. 2014 Feb 26;98:44-58. doi: 10.1016/j.jprot.2013.12.010. Epub 2013 Dec 25.

PMID:
24374379
17.

Long term metabolic syndrome induced by a high fat high fructose diet leads to minimal renal injury in C57BL/6 mice.

Dissard R, Klein J, Caubet C, Breuil B, Siwy J, Hoffman J, Sicard L, Ducassé L, Rascalou S, Payre B, Buléon M, Mullen W, Mischak H, Tack I, Bascands JL, Buffin-Meyer B, Schanstra JP.

PLoS One. 2013 Oct 3;8(10):e76703. doi: 10.1371/journal.pone.0076703. eCollection 2013.

18.

The French Chronic Kidney Disease-Renal Epidemiology and Information Network (CKD-REIN) cohort study.

Stengel B, Combe C, Jacquelinet C, Briançon S, Fouque D, Laville M, Frimat L, Pascal C, Herpe YE, Deleuze JF, Schanstra J, Pisoni RL, Robinson BM, Massy ZA.

Nephrol Dial Transplant. 2014 Aug;29(8):1500-7. doi: 10.1093/ndt/gft388. Epub 2013 Sep 24.

19.

Fetal urinary peptides to predict postnatal outcome of renal disease in fetuses with posterior urethral valves (PUV).

Klein J, Lacroix C, Caubet C, Siwy J, Zürbig P, Dakna M, Muller F, Breuil B, Stalmach A, Mullen W, Mischak H, Bandin F, Monsarrat B, Bascands JL, Decramer S, Schanstra JP.

Sci Transl Med. 2013 Aug 14;5(198):198ra106. doi: 10.1126/scitranslmed.3005807.

20.

Improving peptide relative quantification in MALDI-TOF MS for biomarker assessment.

Albalat A, Stalmach A, Bitsika V, Siwy J, Schanstra JP, Petropoulos AD, Vlahou A, Jankowski J, Persson F, Rossing P, Jaskolla TW, Mischak H, Husi H.

Proteomics. 2013 Oct;13(20):2967-75. doi: 10.1002/pmic.201300100.

PMID:
23943474
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Loading ...
Write to the Help Desk